• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Neuromod Devices

Neuromod raises $10.9M to support neuromod for tinnitus

March 11, 2025 By Sean Whooley

Neuromod Devices announced today that it closed an equity financing round worth proceeds of about $10.9 million (€10 million). The funding comes through an expansion of the company’s Series B round. It adds to the more than $33 million brought in earlier in the round nearly two years ago. Funds support the Dublin, Ireland-based company’s […]

Filed Under: Business/Financial News, Funding Roundup, Neurological, Neuromodulation/Neurostimulation, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Neuromod Devices

Neuromod Devices closes $33.2M financing for tinnitus-treating neuromodulation tech

April 13, 2023 By Sean Whooley

Neuromod Devices announced today that it closed a $33.2 million (€30 million) financing round to support its tinnitus treatment device. Dublin, Ireland–based Neuromod Devices develops Lenire, a neuromodulation device for reducing tinnitus severity. The system received FDA de novo approval in March and has availability throughout Europe. Lenire delivers mild electrical pulses to the tongue […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Neurological, Neuromodulation/Neurostimulation, News Well, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Neuromod Devices

Lenire non-invasive neuromod for tinnitus wins FDA de novo nod

March 9, 2023 By Sean Whooley

Neuromod Devices announced that the FDA granted de novo approval to its Lenire neuromodulation device for treating tinnitus. According to a news release, Lenire becomes the first bimodal neuromodulation device of its kind to receive FDA approval for treating tinnitus. “Lenire’s approval not only means that millions of Americans living with tinnitus can get the […]

Filed Under: Business/Financial News, Food & Drug Administration (FDA), Neurological, Neuromodulation/Neurostimulation, Otolaryngology/Ear, Nose & Throat (ENT), Regulatory/Compliance Tagged With: Neuromod Devices

Neuromod Devices appoints Elsaesser as CCO

March 11, 2020 By Sean Whooley

Non-invasive neuromodulation technology developer Neuromod Devices announced today that it is appointing Florian Elsaesser as its new chief commercial officer. Elsaesser is a 12-year veteran in the space, having worked extensively in the hearing aid industry, according to a news release. He previously held executive positions at Sivantos and Siemens (NYSE:SI) Audiology. Dublin-based Neuromod Devices said […]

Filed Under: Business/Financial News, Neurological, Neuromodulation/Neurostimulation, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Neuromod Devices, Personnel Moves

Eko raises $20m Series B for smart cardiac monitor | Funding Roundup, September 26, 2019

September 26, 2019 By Brad Perriello

Eko said yesterday that it raised a $20 million Series B round for the smart cardiac monitor it’s developing. The San Francisco-based company is working on machine learning technology for a combined digital stethoscope and electrocardiogram, designed for both clinical and at-home monitoring. Eko said more than 3,000 hospitals worldwide use its platform, treating millions […]

Filed Under: Featured, Funding Roundup, Wall Street Beat Tagged With: Cadence Neuroscience, DiagnosisONE, eko, Healionics, InspireMD, Kheiron Medical Technologies, Neuromod Devices, Profound Medical Inc., provisio

Siemens Healthineers taps ex-Abbott Vascular prez Nath to lead lab diag biz | Personnel Moves January 30, 2018

January 30, 2018 By Fink Densford

Siemens (NYSE:SI) Healthineers said today it tapped former Abbott (NYSE:ABT) Vascular president Dr. Deepak Nath as its new laboratory diagnostics business president, taking over for Franz Walt who operated as president from 2014 to 2017. Nath spent 10 years with Abbott, serving most recently as its vascular division president and as an executive officer of the company, and […]

Filed Under: Business/Financial News Tagged With: Abbott, aligntechnology, Amgen, Cardiovascular Systems Inc., CHF Solutions Inc., Cook Group Inc., Endologix, Hillrom, Invetech, Johnson and Johnson, lohmannandrauscher, Medtronic, Neuromod Devices, Novartis, Personnel Moves, Siemens, Surefire Medical

Neuromod raises $6.2m in Series A

September 29, 2015 By Fink Densford

Neuromod said today it raised $6.2 million (EU€5.5 million) in a Series A round of financing, with fund slated to support its mutebutton bi-modal neuromodulation device for patients with chronic tinnitus. Funds from the round came from venture capital firm Fountain Healthcare Partners, the Dublin-based company said. “Neuromod is delighted to announce this investment, which […]

Filed Under: Business/Financial News, Clinical Trials, Neuromodulation/Neurostimulation Tagged With: Neuromod Devices

Neuromod gains CE Mark approval for tinnitus device | Regulatory news for the week of December 1, 2014

December 2, 2014 By MassDevice Contributors Network Leave a Comment

Neuromod wins CE Mark for tinnitus device

November 26, 2014 by Val Kennedy

Filed Under: Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: Animas, Dexcom, GI Dynamics, Johnson and Johnson, Neuromod Devices, Philips, vascularsolutions

Neuromod wins CE Mark for tinnitus device

November 26, 2014 By Val Kennedy Leave a Comment

Neuromod wins CE Mark for tinnitus device

Dublin-based Neuromod Devices said it won CE Mark approval in the European Union for its new multi-sensory device to treat tinnitus, also known as “ear-ringing.”

The product, mutebutton, is a handheld device that helps the brain distinguish between real and phantom noises through audio and tongue stimulation.

Filed Under: Neuromodulation/Neurostimulation, News Well, Regulatory/Compliance Tagged With: CE Mark, Neuromod Devices

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy